KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
13.21 (USD) • At close August 1, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 98.644 | 31.789 | 56.238 | 30.732 | 50.592 | 15.789 | 32.006 | 51.055 | 30.95 | 21.764 | 3.897 | 9.781 | 8.242 |
| Short Term Investments
| 89.002 | 178.612 | 93.137 | 135.47 | 198.337 | 51.925 | 68.805 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 187.646 | 210.401 | 149.375 | 166.202 | 248.929 | 67.714 | 100.811 | 51.055 | 30.95 | 21.764 | 3.897 | 9.781 | 8.242 |
| Net Receivables
| 0 | 10.871 | 16.568 | 0 | 10.418 | 16.527 | 11.315 | 6.834 | 2.547 | 0.356 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 2.709 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Other Current Assets
| 54.044 | 4.418 | 4.307 | 10.638 | 3.616 | 4.455 | 3.42 | 1.491 | 0.701 | 0.668 | 0.218 | 0.129 | 0.083 |
| Total Current Assets
| 241.69 | 225.69 | 172.326 | 193.647 | 264.264 | 88.696 | 115.546 | 59.38 | 34.248 | 24.671 | 4.587 | 9.91 | 8.325 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 1.988 | 9.147 | 10.77 | 10.04 | 7.549 | 3.655 | 2.413 | 1.836 | 0.097 | 0.074 | 0.18 | 0.075 | 0.084 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.199 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 7.092 | 0.567 | 0.106 | 0.193 | 0.2 | 0.178 | 0.173 | 0.173 | 0 | -0.199 | 1.877 | 0.12 | 0.12 |
| Total Non-Current Assets
| 9.08 | 9.714 | 10.876 | 10.233 | 7.749 | 3.833 | 2.586 | 2.009 | 0.097 | 0.074 | 2.057 | 0.195 | 0.204 |
| Total Assets
| 250.77 | 235.404 | 183.202 | 203.88 | 272.013 | 92.529 | 118.132 | 61.389 | 34.345 | 24.745 | 6.644 | 10.105 | 8.529 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 4.883 | 9.107 | 4.817 | 3.638 | 1.981 | 1.677 | 2.86 | 1.433 | 1.153 | 1.008 | 1.024 | 0.462 | 0.147 |
| Short Term Debt
| 1.977 | 1.302 | 1.087 | 0.977 | 0.863 | 0.588 | 0.054 | 0.221 | 0 | 0 | 4.435 | 3.063 | 2.685 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 11 | 0 | 0 | 0 | 0 | 0 | 9.545 | 18.475 | 0 | 0.029 | 0.029 | 0.029 | 0.023 |
| Other Current Liabilities
| 27.307 | 12.398 | 9.128 | 6.961 | 6.93 | 5.455 | 5.593 | 3.087 | 1.865 | 2.212 | 1.605 | 0.396 | 0.213 |
| Total Current Liabilities
| 45.167 | 22.807 | 15.032 | 11.576 | 9.774 | 7.72 | 18.052 | 23.216 | 3.018 | 3.249 | 7.093 | 3.95 | 3.068 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 4.33 | 6.015 | 7.145 | 7.211 | 5.046 | 1.057 | 0 | 0.058 | 0 | 0 | 2.131 | 0 | 0 |
| Deferred Revenue Non-Current
| 105.882 | 0 | 0 | 0 | 0 | 0 | 3.342 | 10.862 | 0 | 0.056 | 0.085 | 0.114 | 0.114 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.862 | 0 | -3.154 | 3.272 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.056 | 38.244 | 39.749 | 33.632 |
| Total Non-Current Liabilities
| 110.212 | 6.015 | 7.145 | 7.211 | 5.046 | 1.057 | 3.342 | 10.92 | 1.153 | 1.008 | 43.732 | 39.863 | 33.746 |
| Total Liabilities
| 155.379 | 28.822 | 22.177 | 18.787 | 14.82 | 8.777 | 21.394 | 34.136 | 3.018 | 3.249 | 50.825 | 43.813 | 36.814 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.608 | 0.026 | 0 | 0 |
| Common Stock
| 0.05 | 0.042 | 0.034 | 0.025 | 0.024 | 0.018 | 0.017 | 0.011 | 0.01 | 0.003 | 0.001 | 0.002 | 0.002 |
| Retained Earnings
| -653.17 | -469.726 | -343.082 | -250.175 | -167.836 | -121.592 | -92.476 | -71.66 | -55.855 | -37.252 | -47.775 | -34.416 | -28.738 |
| Accumulated Other Comprehensive Income/Loss
| -5.214 | -3.488 | -3.06 | -3.861 | -1.432 | -1.882 | -1.926 | -1.109 | -2.643 | -0.075 | -0.495 | -0.441 | -0.414 |
| Other Total Stockholders Equity
| 753.725 | 679.754 | 507.133 | 439.104 | 426.437 | 207.208 | 191.123 | 100.011 | 89.815 | 0.212 | 4.062 | 1.149 | 0.865 |
| Total Shareholders Equity
| 95.391 | 206.582 | 161.025 | 185.093 | 257.193 | 83.752 | 96.738 | 27.253 | 31.327 | 21.496 | -44.181 | -33.708 | -28.285 |
| Total Equity
| 95.391 | 206.582 | 161.025 | 185.093 | 257.193 | 83.752 | 96.738 | 27.253 | 31.327 | 21.496 | -44.181 | -33.708 | -28.285 |
| Total Liabilities & Shareholders Equity
| 250.77 | 235.404 | 183.202 | 203.88 | 272.013 | 92.529 | 118.132 | 61.389 | 34.345 | 24.745 | 6.644 | 10.105 | 8.529 |